Crescent Biopharma, Inc. (CBIO) stock news · rev $10.8M
Crescent Biopharma, Inc. (CBIO) is a biotechnology company listed on NASDAQ.
This CBIO news page leads with what Crescent Biopharma, Inc. filed — not a scraped headline mill.
No cached 8-K sentence for CBIO yet. We will not pad this page with generic market recap.
Latest reported CBIO revenue for 2025-12-31 was $10.8M. Net income was -$153.9M. CBIO currently screens at market cap $491.3M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CBIO stock page; for the tape open the quote page.
CBIO stock news FAQ
What are CBIO's latest revenue and net income?
Latest cached Crescent Biopharma, Inc. (CBIO) revenue for Dec 31, 2025 was $10.8M. Net income was -$153.9M. Statements: https://lician.com/financials/cbio
What is CBIO's market cap?
Crescent Biopharma, Inc. (CBIO) market cap is $491.3M on the latest cached fundamentals snapshot.
What kind of company is CBIO?
Crescent Biopharma, Inc. (CBIO) is a biotechnology company listed on NASDAQ.
Where is CBIO stock news listed?
Cached stock news for Crescent Biopharma, Inc. (CBIO) is listed at https://lician.com/news/cbio. Filings: https://lician.com/sec/cbio
Not investment advice.